Organisations should replace the ‘blame and fear’ approach to phishing with technical measures. This approach ensures threats are managed effectively, mitigating the risk of cyber attacks, rather than creating fear and blame among employees.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
